‘Today’ show's Jill Martin has shared about her breast cancer journey, starting with a diagnosis last month. She discovered a BRCA gene mut...

Ovarian cancer is the third most common gynaecological cancer in India.

The Drugs Controller General of India (DCGI) has approved Lynparza (Olaparib) as a monotherapy for the treatment of adult patients with ear...

The size of the industry, which is pegged at Rs 300-400 crore, has been growing at 30% annually.

Most women mistake myths for facts and avoid getting themselves checked.

Aldehydes are a class of chemicals made in our own bodies in small quantities but increasingly found everywhere in our environment.

Kolkata, Sep 26 (IANS) Bolstering the knowhow behind targeted cancer treatment, Indian scientists have offered a new rationale for combinat...

Ovarian cancer is diagnosed annually in nearly a quarter of a million women globally. How aware are you about the disease? Take this quiz t...

Men ranked in the highest percentiles for risk in the study have a prostate cancer risk comparable to the breast cancer risk among women.

About 5 to 10 per cent of all cancers are caused by known inherited gene mutations. These mutations are passed down from generation to gene...

Women who carried rare mutations in PALB2 were found to have on average a one in three chance of developing breast cancer by the age of 70.

Breast cancer is the most prevalent cancer among Indian women with approximately 1.5 lakh new patients being diagnosed every year.

The US SC will rule on Monday on a case challenging some patents by a company that offers predictive genetictesting services for breast can...